Technical Analysis for ENTA - Enanta Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade D 76.9 3.22% 2.40
ENTA closed up 3.22 percent on Friday, January 18, 2019, on approximately normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Earnings due: Feb 6

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical ENTA trend table...

Date Alert Name Type % Chg
Jan 18 Crossed Above 50 DMA Bullish 0.00%
Jan 17 MACD Bullish Centerline Cross Bullish 3.22%
Jan 17 NR7 Range Contraction 3.22%
Jan 16 Fell Below 50 DMA Bearish 4.50%
Jan 16 180 Bearish Setup Bearish Swing Setup 4.50%
Jan 15 Crossed Above 50 DMA Bullish 1.46%
Jan 15 180 Bullish Setup Bullish Swing Setup 1.46%
Jan 14 50 DMA Resistance Bearish 5.60%
Jan 14 Outside Day Range Expansion 5.60%
Jan 11 50 DMA Resistance Bearish 2.45%

Older signals for ENTA ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Enanta Pharmaceuticals, Inc., a biotechnology company, engages in the development of small molecule drugs for the infectious disease areas. Its product candidates include ABT-450, an inhibitor of NS3 protease that is in Phase III clinical trials for the treatment of hepatitis C virus (HCV) infection; EDP-239, an NS5A Inhibitor for HCV infection; EDP-546, a Cyclophilin inhibitor, which is in preclinical studies for HCV infection treatment; and Nucleotide Polymerase inhibitor for HCV infection. The company also develops EDP-788, an intravenous drug for the treatment of methicillin-resistant Staphylococcus aureus bacteria. It has collaboration and license agreements with Novartis Institutes for BioMedical Research, Inc. and Abbott Laboratories. The company was founded in 1995 and is headquartered in Watertown, Massachusetts.
Is ENTA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 127.77
52 Week Low 64.085
Average Volume 263,040
200-Day Moving Average 91.2003
50-Day Moving Average 75.37
20-Day Moving Average 72.124
10-Day Moving Average 74.764
Average True Range 3.6095
ADX 15.94
+DI 20.5069
-DI 13.1095
Chandelier Exit (Long, 3 ATRs ) 66.52149999999999
Chandelier Exit (Short, 3 ATRs ) 74.91349999999999
Upper Bollinger Band 78.5916
Lower Bollinger Band 65.6564
Percent B (%b) 0.87
BandWidth 17.934668
MACD Line 0.303
MACD Signal Line -0.3364
MACD Histogram 0.6394
Fundamentals Value
Market Cap 1.47 Billion
Num Shares 19.1 Million
EPS -1.08
Price-to-Earnings (P/E) Ratio -71.20
Price-to-Sales 23.12
Price-to-Book 3.52
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 81.58
Resistance 3 (R3) 81.10 79.06 80.80
Resistance 2 (R2) 79.06 77.87 79.30 80.54
Resistance 1 (R1) 77.98 77.13 78.52 78.46 80.28
Pivot Point 75.94 75.94 76.21 76.18 75.94
Support 1 (S1) 74.86 74.75 75.40 75.34 73.52
Support 2 (S2) 72.82 74.01 73.06 73.26
Support 3 (S3) 71.74 72.82 73.00
Support 4 (S4) 72.22